Outsourcing STREAM

  1. Navigating The Unique Attributes Of Psychedelic Drug Development 1/22/2024

    Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.

  2. How Sponsors Turn Disclosure As A Service Into A Strategic Advantage 5/18/2020

    In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.

  3. Successful Implementation Of A Drug-Device Combination Submission 11/21/2025

    Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.

  4. Altasciences Has You Covered From Coast To Coast 1/30/2023

    With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.

  5. Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments 5/5/2023

    Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.